Safety and Efficacy of Vagus Nerve Stimulation in Fibromyalgia: A Phase I/II Proof of Concept Trial

Pain Medicine

Volumn 12, Issue 9, 2011, Pages 1406-1413

  Lange, Gudrun ^a,b   Janal, Malvin N ^a,d   Maniker, Allen ^c   Fitzgibbons, Jennifer ^a,b   Fobler, Malusha ^a,b   Cook, Dane ^e   Natelson, Benjamin H ^a,c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Chronic Pain; Fibromyalgia; Neurology

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; FATIGUE; FEMALE; FIBROMYALGIA; FOLLOW UP; HUMAN; PAIN ASSESSMENT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHYSICAL PERFORMANCE; TREATMENT OUTCOME; TREATMENT RESPONSE; VAGUS NERVE STIMULATION; WELLBEING; XEROSTOMIA;

EID: 80052837771     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01203.x     Document Type: Article

References (19)

1. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
2. Randich A, Gebhart GF. Vagal afferent modulation of nociception. Brain Res Brain Res Rev 1992;17:77-99.
3. Arnold LM, Goldenberg DL, Stanford SB, etal. Gabapentin in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 2007;56:1336-44.
4. Russell IJ, Mease PJ, Smith TR, etal. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 2008;136:432-44.
5. Borckardt JJ, Kozel FA, Anderson B, Walker A, George MS. Vagus nerve stimulation affects pain perception in depressed adults. Pain Res Manag 2005;10:9-14.
6. Wechsler D. Wechsler Adult Intelligence Scale-Revised Manual. New York: Psychological Corporation; 1981.
7. Sheehan DV, Lecrubier Y, Sheehan KH, etal. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33.
8. Wolfe F, Smythe HA, Yunus MB, etal. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
9. Okifuji A, Turk DC, Sinclair JD, Starz TW, Marcus DA. A standardized manual tender point survey. 1. development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome. J Rheumatol 1997;24:377-83.
10. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
11. Margolis RB, Tait RC, Krause SJ. A rating system for use with patient pain drawings. Pain 1986;24:57-65.
12. Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y. Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008;30:1988-2004.
13. Cyberonics Inc. Epilepsy Physicians' Manual, Neuro Cybernetic Prosthesis System NCP Pulse Generator, Models 100 and 101. 2002. Available at: (accessed July 19, 2011).
14. Cyberonics Inc. Depression Information. VNS Therapy™ Pulse Generators. For Health Care Professionals. 23. 2008. Houston TX.
15. Connolly SJ, Sheldon R, Thorpe KE, etal. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): A randomized trial. JAMA 2003;289:2224-9.
16. Cobb LA, Thomas GI, Dillard DH, Merendno KA, Bruce RA. An evaluation of internal-mammary-artery ligation by a double-blind technic. N Engl J Med 1959;260:1115-8.
17. McRae C, Cherin E, Yamazaki TG, etal. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Gen Psychiatry 2004;61:412-20.
18. Moseley JB, O'Malley K, Petersen NJ, etal. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2002;347:81-8.
19. Morris GL III, Mueller WM. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology 1999;53:1731-5.